Risk of Islet and Celiac Autoimmunity in Cotwins of Probands With Type 1 Diabetes.

Journal of the Endocrine Society
Taylor M TrioloAndrea K Steck

Abstract

Concordance for persistent islet autoimmunity (IA) and type 1 diabetes in monozygotic twins after probands are diagnosed is variable (30%-70%). Risk for development of IA in dizygotic twins is thought to be similar to nontwin siblings. Little is known in regard to the development of celiac autoimmunity (CDA) in twins of subjects with type 1 diabetes. Our aim was to investigate the development of IA and CDA in cotwins of probands with type 1 diabetes. Since 1995, the Twin Family Study has followed 336 twins (168 twin probands with type 1 diabetes and 168 cotwins) for a median of 14 years (interquartile range:10-18 years). Cotwins were followed for the development of IA, type 1 diabetes, and CDA. In monozygotic cotwins, cumulative incidence by age 20 was 14% for IA and 10% for CDA. Development of IA and CDA by age 20 was 9% and 12% in dizygotic cotwins, respectively. While the numbers are small, IA by age 30 years was 26% in monozygotic and 39% in dizygotic twins. In proportional hazards models, the proband's younger age at diagnosis, but not sex or human leukocyte antigen were associated with time to IA and CDA in cotwins. CDA risk by age 20 in cotwins was 10% to 12%. With long-term follow-up, cumulative incidence for IA is high...Continue Reading

References

May 31, 2001·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·P M GillettH J Freeman
Oct 20, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ludvig M Sollid, Benedicte A Lie
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Janet M WenzlauJohn C Hutton
Feb 7, 2008·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Julianne CondonDavid L Duffy
Jul 1, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alberto Rubio-TapiaJoseph A Murray
Dec 26, 2008·The New England Journal of Medicine·Maria J RedondoTihamer Orban
Mar 25, 2011·Diabetes Care·Taylor M TrioloJennifer M Barker
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Mikael Knip, Olli Simell
Apr 24, 2013·The American Journal of Gastroenterology·Alberto Rubio-TapiaUNKNOWN American College of Gastroenterology
Jun 20, 2013·JAMA : the Journal of the American Medical Association·Anette G ZieglerGeorge S Eisenbarth
Jul 6, 2014·The New England Journal of Medicine·Edwin LiuUNKNOWN TEDDY Study Group
May 23, 2015·Diabetes Care·Ezio Bonifacio
Jun 17, 2015·Pediatrics·Anna Pham-ShortMaria E Craig
Feb 24, 2016·Autoimmunity Reviews·George J Kahaly, Martin P Hansen
May 27, 2017·Diabetes Care·Maria E CraigUNKNOWN Prospective Diabetes Follow-up Registry (DPV) initiative
Oct 12, 2017·Pediatrics·William HagopianUNKNOWN TEDDY Study Group
Aug 1, 2018·Diabetes Care·Taylor M TrioloUNKNOWN Type 1 Diabetes TrialNet Study Group
Oct 27, 2018·Diabetes Care·Jing W HughesJanet B McGill

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping

Software Mentioned

HLA Fusion
SAS

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.